BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24129801)

  • 21. N-terminal pro-brain natriuretic peptide identifies patients at risk for occurence of postoperative atrial fibrillation in cardiac surgery with cardiopulmonary bypass.
    Samy K; Anouar J; Mnif E; Imed F; Fatma A; Abdelhamid K
    Ann Card Anaesth; 2012; 15(3):199-205. PubMed ID: 22772514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery.
    Wazni OM; Martin DO; Marrouche NF; Latif AA; Ziada K; Shaaraoui M; Almahameed S; Schweikert RA; Saliba WI; Gillinov AM; Tang WH; Mills RM; Francis GS; Young JB; Natale A
    Circulation; 2004 Jul; 110(2):124-7. PubMed ID: 15210589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative high N-terminal pro-B-type natriuretic peptide level can predict the incidence of postoperative atrial fibrillation following off-pump coronary artery bypass grafting.
    Matsuura K; Mogi K; Sakurai M; Kawamura T; Misue T; Hatakeyama I; Takahara Y
    Ann Thorac Cardiovasc Surg; 2013; 19(5):375-81. PubMed ID: 23269269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.
    Staszewsky L; Meessen JMTA; Novelli D; Wienhues-Thelen UH; Disertori M; Maggioni AP; Masson S; Tognoni G; Franzosi MG; Lucci D; Latini R
    BMC Cardiovasc Disord; 2021 Nov; 21(1):553. PubMed ID: 34798808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
    Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG
    Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
    Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G
    Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between left atrial appendage emptying velocity, N-terminal plasma brain natriuretic peptide levels, and recurrence of atrial fibrillation after catheter ablation.
    Ma XX; Zhang YL; Hu B; Jiang WJ; Wang M; Zheng DY; Zhu MR; Xue XP
    J Interv Card Electrophysiol; 2017 Apr; 48(3):343-350. PubMed ID: 27943042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between plasma brain natriuretic peptide/N-terminal pro-brain natriuretic peptide levels and atrial fibrillation: evidence from a meta-analysis.
    Liu Y; Xiao Y; Chen X; Zhang F
    Chin Med J (Engl); 2014; 127(15):2824-8. PubMed ID: 25146622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
    J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.
    Ryding AD; Kumar S; Worthington AM; Burgess D
    Anesthesiology; 2009 Aug; 111(2):311-9. PubMed ID: 19602961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation after thoracic surgery for lung cancer: use of a single cut-off value of N-terminal pro-B type natriuretic peptide to identify patients at risk.
    Salvatici M; Cardinale D; Spaggiari L; Veglia F; Tedesco CC; Solli P; Cipolla CM; Zorzino L; Passerini R; Riggio D; Cassatella MC; Sandri MT
    Biomarkers; 2010 May; 15(3):259-65. PubMed ID: 20030573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design.
    Engdahl J; Svennberg E; Friberg L; Al-Khalili F; Frykman V; Kemp Gudmundsdottir K; Fredriksson T; Rosenqvist M
    Europace; 2017 Feb; 19(2):297-302. PubMed ID: 28011798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
    Sinner MF; Stepas KA; Moser CB; Krijthe BP; Aspelund T; Sotoodehnia N; Fontes JD; Janssens AC; Kronmal RA; Magnani JW; Witteman JC; Chamberlain AM; Lubitz SA; Schnabel RB; Vasan RS; Wang TJ; Agarwal SK; McManus DD; Franco OH; Yin X; Larson MG; Burke GL; Launer LJ; Hofman A; Levy D; Gottdiener JS; Kääb S; Couper D; Harris TB; Astor BC; Ballantyne CM; Hoogeveen RC; Arai AE; Soliman EZ; Ellinor PT; Stricker BH; Gudnason V; Heckbert SR; Pencina MJ; Benjamin EJ; Alonso A
    Europace; 2014 Oct; 16(10):1426-33. PubMed ID: 25037055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma renin activity and pro-B-type natriuretic peptide levels in different atrial fibrillation types.
    Doğan A; Gedikli O; Ozaydin M; Acar G
    Anadolu Kardiyol Derg; 2010 Aug; 10(4):317-22. PubMed ID: 20693126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery.
    Chong CP; Ryan JE; van Gaal WJ; Lam QT; Sinnappu RN; Burrell LM; Savige J; Lim WK
    Am J Cardiol; 2010 Sep; 106(6):865-72. PubMed ID: 20816130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.
    Fan J; Cao H; Su L; Ling Z; Liu Z; Lan X; Xu Y; Chen W; Yin Y
    J Interv Card Electrophysiol; 2012 Jan; 33(1):93-100. PubMed ID: 21938519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma N-terminal pro-B-type natriuretic peptide is predictive of perioperative cardiac events in patients undergoing vascular surgery.
    Yang JH; Choi JH; Ki YW; Kim DI; Kim DK; Park JR; Oh JK; Choi SH
    Korean J Intern Med; 2012 Sep; 27(3):301-10. PubMed ID: 23019395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery.
    Chong CP; Lim WK; Velkoska E; van Gaal WJ; Ryan JE; Savige J; Burrell LM
    Am J Cardiol; 2012 May; 109(9):1365-73. PubMed ID: 22381157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.